4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023265
Chief Medical Officer bought 5,000 shares at $5.06 ($25,311)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Clark David J Chief Medical Officer | 2019-09-06 | Purchase | +5,000 | $5.06 | $25,311 | 17,878 | D: show line 1 in the form |
| Open-market purchases · 5,000 sh · avg $5.06 · $25,311 | |||||||
Loading xslF345X03/doc4.xml…